Cancer remains a significant risk to human health. Nanomedicine is a new multidisciplinary
field that is garnering a lot of interest and investigation. Nanomedicine shows great potential …

Functional nucleic acid (NA)-based drugs have a broad range of applications since they
allow the alteration and control of gene/protein expression patterns in cells. In principle …

Using nanoparticles to carry and delivery anticancer drugs holds much promise in cancer
therapy, but nanoparticles per se are lacking specificity. Active targeting, that is, using …

Targeted exosomal delivery systems for precision nanomedicine attract wide interest across
areas of molecular cell biology, pharmaceutical sciences, and nanoengineering. Exosomes …

Triple negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC) are amongst
the most aggressive forms of solid tumors. TNBC is highlighted by absence of genetic …

Flavonoids, a ubiquitous group of naturally occurring polyphenolic compounds, have
recently gained importance as anticancer agents. Unfortunately, due to low solubility …

The mucin (MUC) family is a group of highly glycosylated macromolecules that are
abundantly expressed in mammalian epithelial cells. MUC proteins contribute to the …

Highlights•Flavonoids exhibit therapeutic potential against different types of cancer
cells.•Poor pharmacokinetics and biopharmaceutical traits limit their therapeutic …

Cancers are complex diseases orchestrated by a plethora of extrinsic and intrinsic factors.
Research spanning over several decades has provided better understanding of complex …

MicroRNAs (miRNAs) are short non-coding RNAs that regulate gene expression through
mRNA degradation or translation inhibition. MiRNAs play important roles in a variety of …